Echocardiographic study of paediatric patients with mucopolysaccharidosis

Abstract

Principle: Mucopolysaccharidosis is an inborn error of metabolism causing glucosaminoglycans tissue storage. Cardiovascular involvement is variable but contributes significantly towards the morbidity and mortality of the patients. Objective: To characterise the echocardiographic abnormalities in children and adolescents with different types of mucopolysaccharidosis. Method: Echocardiograms and medical records of 28 patients aged 2-14 years, seen from 2003 to 2005, were revised. At that time, the enzymatic replacement therapy was still not available in our institution. Results: Echocardiographic alterations were detected in 26 patients (93%), whereas 16 (57%) had abnormal auscultation, and only 6 (21%) presented with cardiovascular complaint. Mitral valve thickening with dysfunction (regurgitation, stenosis, or double lesion) was diagnosed in 60.8%, left ventricular hypertrophy in 43% and aortic valve thickening with regurgitation in 35.8% of the patients. There was no systolic dysfunction and mild left diastolic dysfunction was shown in 21.5% of the patients. Pulmonary hypertension was present in 36% of the patients, causing the only two deaths recorded. There was a strong association between the accumulation of dermatan sulphate and the presence of mitral valve dysfunction (p 5 0.0003), aortic valve dysfunction (p 5 0.006), and pulmonary hypertension (p 5 0.006). Among individuals with two or more examinations, 82% had a worsening evolution. Conclusions: Echocardiographic alterations in children with Mucopolysaccharidosis are frequent and have a progressive character. Left valve lesions, ventricular hypertrophy, and pulmonary hypertension were the most common findings and there was an association between the accumulation of dermatan sulphate and cardiovascular involvement. Unlike in adults, pulmonary hypertension was the main cause of death, not left ventricle systolic dysfunction.

Clinical Evolution After Enzyme Replacement Therapy in Twins with the Severe Form of Maroteaux–Lamy Syndrome

“…These abnormalities are stabilized by galsulfase treatment (Brands et al 2013;Giugliani et al 2014). We found mild mitral insufficiency in both twins, although mitral valve regurgitation is described in most MPS VI pediatric reports (Azevedo et al 2004;Scarpa et al 2009;Fesslova et al 2009;Lael et al 2010). However, Twin 2 also presented tricuspid and aortic involvement.…”

Fatal and Unanticipated Cardiorespiratory Disease in a Two-Year-Old Child with Hurler Syndrome Following Successful Stem Cell Transplant

“…Cardiac disease in MPS 1 has a prevalence and severity believed to be in the range of 60-100 % of those studied and ranges from severe dilated cardiomyopathy presenting within days or weeks of birth to identification of thickened and incompetent cardiac valves in otherwise asymptomatic individuals (Leal et al 2010;Braunlin et al 2011;Wiseman et al 2012). While valvular abnormalities and coronary artery disease are most frequently documented, vascular changes in great vessels and conduction abnormalities have also been described.…”

Enfermedad de Morquio (mucopolisacaridosis IV-A): aspectos clínicos, diagnósticos y nuevo tratamiento con terapia de reemplazo enzimático

“…21 Otros estudios que no diferencian entre MPS IV-A y B mostraron estenosis valvular entre el 7 y el 9% e insuficiencia valvular entre el 17 y el 26% de los casos estudiados. 22 A la fecha, se ha reportado una mujer embarazada con fenotipo grave de MPS IV-A, quien concluyó su embarazo en la semana 28 por disnea e intolerancia al dolor. La hija evolucionó con enfermedad de membrana hialina, anemia, hiperbilirrubinemia, apneas y displasia broncopulmonar.…”